Britons paying privately for obesity drugs are increasingly choosing Eli Lilly's Mounjaro over Novo Nordisk's Wegovy, online pharmacies say, in a sign the U.S. drugmaker is gaining ground on its ...

Studies suggest that semaglutide reduces heart attack and stroke and may curb addiction and more. Scientists reflect on the future of GLP-1 drugs beyond weight loss.

With so many weight loss medications on the market, it's easy to feel overwhelmed by the options. From brand-name heavy ...

They’ve been heralded as the magic drugs that treat obesity when diet and exercise have failed. But Ozempic and Wegovy – and ...

But in a twist this August, a separate part of North Carolina’s government allowed the Medicaid program to start covering the ...

Meds like Wegovy are all over the news. But are they right for you, especially if you’re older than the average user?

They are currently approved for treating diabetes, obesity and those with a history of cardiovascular disease in people who ...

Weight loss drugs such as Ozempic and Wegovy are increasingly popular among adults, who have flocked to the new medication as ...

Results from a recent survey have prompted questions about the influence of GLP-1s on the obesity rate of U.S. adults.

As demand for obesity drugs like Wegovy, Zepbound, Mounjaro and Ozempic, outpaces supply, online scams are rising, according ...

Patients self-administer the drug using a pre-dosed injector pen, but Lilly recently introduced the product in single-dose ...

Novo Nordisk, the manufacturer of Ozempic and Wegovy, has petitioned the Food and Drug Administration (FDA) to add ...